Evaluation of fever of unknown origin in adults
Summary
Diagnósticos diferenciais
comuns
- Tuberculosis (TB)
- Abdominal or pelvic abscess
- HIV
- Rhinosinusitis, acute or chronic
- Bacterial pneumonia
- Urinary tract infection
Incomuns
- Infective endocarditis
- Dental abscesses
- Osteomyelitis
- Prostatitis, acute or chronic
- Cytomegalovirus infection
- Epstein-Barr virus infection
- Coronavirus disease 2019 (COVID-19)
- Rheumatic fever
- Lyme disease
- Chronic myeloid leukemia
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Metastatic carcinoma, primary unknown
- Renal cancer
- Myelodysplastic syndrome
- Adult-onset Still disease
- Polymyalgia rheumatica
- Giant cell arteritis
- Systemic lupus erythematosus
- Crohn disease
- Ulcerative colitis
- Rheumatoid arthritis
- Reactive arthritis
- Drug-induced fever
- Cirrhosis, complicated
- Hepatitis
- Deep vein thrombosis
- Sarcoidosis
- Periodic fever syndromes
- Malaria
- Typhoid fever
- Rocky Mountain spotted fever
- Ascariasis
- Tularemia
- Brucellosis
- Psittacosis
- Q fever
- Pheochromocytoma
- Hyperthyroidism
- Munchausen syndrome
- Dengue fever
Colaboradores
Autores
William F. Wright, DO, MPH
Assistant Professor
Division of Infectious Diseases, Department of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD
Declarações
WFW declares that he has no competing interests.
Paul G. Auwaerter, MD
Professor
Division of Infectious Diseases, Department of Medicine
The Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, MD
Declarações
PGA has equity holdings in Johnson & Johnson, and does ongoing Lyme disease vaccine research funded by Pfizer. He has been a consultant to Shionogi regarding coronavirus disease and is on the board of directors for Capricor, which has an investigational product for Duchenne muscular dystrophy. He has an unpaid position on the board of directors for the American Lyme Disease Foundation.
Agradecimentos
Dr William F. Wright and Dr Paul G. Auwaerter would like to gratefully acknowledge Dr Roth and Dr Basello, previous contributors to this topic.
Revisores
Kevin P. High, MD, MS, MACP, FIDSA
Professor of Medicine
Wake Forest University School of Medicine
Vice Chief Academic Officer, aLHS, Advocate Health
Winston-Salem, NC
Declarações
KPH declares that he has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Haidar G, Singh N. Fever of unknown origin. N Engl J Med. 2022 Feb 3;386(5):463-77. Resumo
Cunha BA, Lortholary O, Cunha CB. Fever of unknown origin: a clinical approach. Am J Med. 2015 Oct;128(10):1138.e1-1138.e15.Texto completo Resumo
Wright WF, Auwaerter PG. Fever and fever of unknown origin: review, recent advances, and lingering dogma. Open Forum Infect Dis. 2020 May;7(5):ofaa132.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
O uso deste conteúdo está sujeito ao nosso aviso legal